HAO$1.89-3.57%
Haoxi Health Technology Ltd
Sector: Services-Advertising AgenciesIndustry: Advertising AgenciesCountry: CNExchange: Nasdaq
Mkt Cap:$1.21M
Float & O/S:
Inst Own:
DilutionScan read 19 of Haoxi Health Technology Ltd's SEC filings and found 5 warrant series, 1 ATM program, 1 shelf registration and 5 completed offerings on file for HAO. The latest dilution event on file is an offering on Jul 13, 2026. Analysis updated Oct 13, 2026.
Signal8 Summary
HAO
Going-concern warning, two reverse splits
Snapshot
Haoxi is a tiny Chinese digital-marketing micro-cap with FY 2025 revenue of $32.8M, down 32.4% from a year earlier, and a razor-thin 2.8% gross margin. It lost money operationally (-$2.0M operating income) and burned $3.4M in free cash flow, against just $6.8M in cash.
What's Happening Right Now
- : Haoxi effected a second reverse share split, 1-for-20, effective August 14, 2026, cutting Class A shares from about 11.9 million to roughly 595,000, intended to meet Nasdaq's minimum bid price rule.
- : Short interest jumped 810.7% in July 2026 to about 545,000 shares, roughly 7.4% of the float at the time.
- : On July 14, 2026, Haoxi signed a strategic cooperation framework with NOVA MEDIA to build an AI digital marketing system using generative AI and digital humans; no financial terms were disclosed.
- : Haoxi closed a registered direct offering on July 14, 2026, raising $4M gross by selling shares and pre-funded warrants through Univest Securities, with proceeds earmarked for working capital and possible acquisitions.
- : A July 13, 2026 prospectus disclosed an auditor's report expressing substantial doubt about the company's ability to continue as a going concern, alongside a $4M offering priced at $0.40/share following a 128-for-1 reverse split.
